SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-16-010661
Filing Date
2016-12-30
Accepted
2016-12-30 09:08:24
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 6-K sbbp-20160930x6k.htm 6-K 1258140
  Complete submission text file 0001558370-16-010661.txt   4411669

Data Files

Seq Description Document Type Size
2 EX-101.INS sbbp-20160930.xml EX-101.INS 816777
3 EX-101.SCH sbbp-20160930.xsd EX-101.SCH 37311
4 EX-101.CAL sbbp-20160930_cal.xml EX-101.CAL 39122
5 EX-101.DEF sbbp-20160930_def.xml EX-101.DEF 129108
6 EX-101.LAB sbbp-20160930_lab.xml EX-101.LAB 368612
7 EX-101.PRE sbbp-20160930_pre.xml EX-101.PRE 247141
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 6-K | Act: 34 | File No.: 001-37569 | Film No.: 162076441
SIC: 2834 Pharmaceutical Preparations